FF:0000343: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{F5terms | {{F5terms | ||
| | |alt_id= | ||
|comment= | |comment= | ||
|created_by=tmeehan | |created_by=tmeehan | ||
| | |def= | ||
|derives_from= | |derives_from= | ||
|develops_from= | |develops_from= | ||
|disjoint_from= | |||
|has_quality= | |has_quality= | ||
|id=FF:0000343 | |||
|is_a=EFO:0000727 | |||
|is_obsolete= | |||
|located_in= | |located_in= | ||
|name=control treatment | |||
|namespace=FANTOM5 | |||
|obo_creation_date=2011-04-29T09:50:26Z | |||
|part_of= | |part_of= | ||
|preceded_by= | |||
|property_value= | |property_value= | ||
| | |subset= | ||
| | |synonym= | ||
|union_of= | |||
|xref= | |||
}} | }} | ||
Revision as of 10:39, 12 September 2014
outline
- id: FF:0000343
- name: control treatment
- namespace: FANTOM5
- created_by: tmeehan
- creation_date: 29 April 2011 09:50:26
- CAGEd oPOSSUM: NA
Ontology association
Parents
| is_a: | EFO:0000727(treatment) |
|---|
Children
| is a: | FF:0000407 (whole cell (cellular fractionation control)),FF:0000592 (human H9 Embryonic Stem cells sample),FF:0000648 (mock infection sample),FF:0000707 (human mesenchymal stem cells adipose derived, untreated control sample),FF:0000710 (human Saos2 osteosarcoma cell line timecourse control sample),FF:0000730 (human melanocyte (MC) sample),FF:0011101 (human CD14-positive monocytes - mock treated sample),FF:0011132 (human Hep-2 cells mock treated sample),FF:0011450 (CD4-positiveCD25-CD44- naive conventional T cells- (C57BL_6J) sample),FF:0011451 (CD4-positiveCD25-CD44- naive conventional T cells- (Balb_cAJcl) sample),FF:0011454 (CD4-positiveCD25-positive regulatory T cells (C57BL_6J) sample),FF:0011455 (CD4-positiveCD25-positive regulatory T cells (Balb_cAJcl) sample),FF:0011468 (mouse CD41-positive megakaryocyte control sample),FF:0011508 (mouse TSt-4/DLL1 feeder cells sample),FF:10003-101A7 (SABiosciences XpressRef Mouse Universal Total RNA, pool1),FF:10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1),FF:10101-102D4 (whole body, embryo E17.5, pool1 (internal control)),FF:10449-106F8 (cord blood derived cell line:COBL-a untreated),FF:12680-135B7 (),FF:12681-135B8 (),FF:12682-135B9 (),FF:12683-135C1 (),FF:12684-135C2 (),FF:12685-135C3 (),FF:12686-135C4 (),FF:12687-135C5 (),FF:12688-135C6 (),FF:12689-135C7 (),FF:12690-135C8 (),FF:12691-135C9 (),FF:12692-135D1 (),FF:12693-135D2 (),FF:12694-135D3 (),FF:12695-135D4 (),FF:12696-135D5 (),FF:12697-135D6 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)),FF:12778-136D6 (),FF:12779-136D7 (),FF:12780-136D8 (),FF:12781-136D9 (),FF:12782-136E1 (),FF:12783-136E2 (),FF:12784-136E3 (),FF:12785-136E4 (),FF:12786-136E5 (),FF:12787-136E6 (),FF:12788-136E7 (),FF:12789-136E8 (),FF:12790-136E9 (),FF:12791-136F1 ()... further results |
|---|
FF Samples
Human
- 10449-106F8 (cord blood derived cell line:COBL-a untreated)
- 12680-135B7
- 12681-135B8
- 12682-135B9
- 12683-135C1
- 12684-135C2
- 12685-135C3
- 12686-135C4
- 12687-135C5
- 12688-135C6
- 12689-135C7
- 12690-135C8
- 12691-135C9
- 12692-135D1
- 12693-135D2
- 12694-135D3
- 12695-135D4
- 12696-135D5
- 12697-135D6 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17))
- 12778-136D6
- 12779-136D7
- 12780-136D8
- 12781-136D9
- 12782-136E1
- 12783-136E2
- 12784-136E3
- 12785-136E4
- 12786-136E5
- 12787-136E6
- 12788-136E7
- 12789-136E8
- 12790-136E9
- 12791-136F1
- 12792-136F2
- 12793-136F3
- 12794-136F4
- 12795-136F5 (Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17))
- 12876-137F5
- 12877-137F6
- 12878-137F7
- 12879-137F8
- 12880-137F9
- 12881-137G1
- 12882-137G2
- 12883-137G3
- 12884-137G4
- 12885-137G5
- 12886-137G6
- 12887-137G7
- 12888-137G8
Mouse
- 10003-101A7 (SABiosciences XpressRef Mouse Universal Total RNA, pool1)
- 10008-101B6 (Universal RNA - Mouse Normal Tissues Biochain, pool1)
- 10101-102D4 (whole body, embryo E17.5, pool1 (internal control))
